Xxera/openscience/retractions

Record #52601

SHCBP1 promotes papillary thyroid carcinoma carcinogenesis and progression through promoting formation of integrin and collagen and maintaining cell stemness

Houfa Geng, Mengzhe Guo, Wei Xu, Xiu Zang, Tingting Wu, Fei Teng, Yu Wang, Xuekui Liu, Xiuli Wang, Qiang Sun, Jun Liang

Journal

Frontiers in Endocrinology

Publisher

Original paper date

Feb 26, 2021

Original DOI

10.3389/fendo.2020.613879

Country

Institution

Department of Endocrinology, Affiliated Hospital of Medical College of Southeast University and Xuzhou Central Hospital, Xuzhou, China · Xuzhou Clinical School, Xuzhou Medical University, Xuzhou, China · Xuzhou Clinical School, Nanjing Medical University, Xuzhou, China · Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China · Cancer Institute, Xuzhou Medical University, Xuzhou, China · Xuzhou Institute of Medical Science, Postgraduate Workstation of Soochow University, Xuzhou, China

Open access

No

Article type

Research Article

Broad categories

(BLS) Biochemistry (BLS) Biology - Cancer (BLS) Biology - Cellular (BLS) Genetics

Notes from Retraction Watch

see also: https://pubpeer.com/publications/3757870ACA856C40F857706BE00EC7

Citation lifecycle

How this paper is being cited

Pre-retraction

5

Same day

0

Post-retraction

1

% post-retraction

16.7%

~1.7 citations/yr before retraction · ~0.4 citations/yr after

— citing papers

Who is still citing this work

Loading…